TY - JOUR
T1 - IL-17 signalling is critical for controlling subcutaneous adipose tissue dynamics and parasite burden during chronic murine Trypanosoma brucei infection
AU - Sinton, Matthew C.
AU - Chandrasegaran, Praveena R. G.
AU - Capewell, Paul
AU - Cooper, Anneli
AU - Girard, Alex
AU - Ogunsola, John
AU - Perona-Wright, Georgia
AU - Ngoyi, Dieudonné M
AU - Kuispond, Nono
AU - Bucheton, Bruno
AU - Camara, Mamadou
AU - Kajimura, Shingo
AU - Bénézech, Cécile
AU - Mabbott, Neil A.
AU - MacLeod, Annette
AU - Quintana, Juan F.
N1 - Funding Information:
We firstly thank the TrypanoGEN Network for providing serum samples from patients. We also thank Jean Rodgers for the use of her project licence for performing animal work. We thank the Histology Research Service at Veterinary Diagnostic Services, School of Veterinary Medicine, University of Glasgow. We also thank Nicola Munro, Craig Begley, Scott McCall and Catrina Boyd at the Veterinary Research Facility (University of Glasgow) for maintaining optimal husbandry conditions and comfort for the animals used in this study. We thank Julie Galbraith and Pawel Herzyk (Glasgow Polyomics, University of Glasgow) for their support with single-cell library preparation and sequencing. Finally, the authors would like to thank the Flow Cytometry Core Facility, University of Manchester, UK, for mass cytometry sample acquisition. This work was funded in part by a Wellcome Trust Institutional Strategic Support Fund award (316917-01 awarded to M.C.S.), a Society for Endocrinology Early Career Grant (316705/0 awarded to M.C.S.), and a Wellcome Centre for Integrative Parasitology FutureScope grant [174811-23] to M.C.S. This work was also funded in part by a Wellcome Trust Senior Research Fellowship (209511/Z/17/Z awarded to A.M.L.). J.F.Q. is funded by a Sir Henry Wellcome postdoctoral fellowship (221640/Z/20/Z awarded to J.F.Q.). P.C. is funded by a Wellcome Centre for Integrative Parasitology FutureScope grant to J.F.Q. (104111/Z/14/Z awarded to J.Q.). G.P.W. is funded by an MRC grant (MR/S009779/1). CB is funded by an MRC grant (MR/W018497/1). NAM is supported by the BBSRC Institute Strategic Programme (BBS/E/D/20002173 and BB/X010937/1). S.K. is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (DK97441, DK125281 and DK127575) and the Howard Hughes Medical Institute.
Funding Information:
We firstly thank the TrypanoGEN Network for providing serum samples from patients. We also thank Jean Rodgers for the use of her project licence for performing animal work. We thank the Histology Research Service at Veterinary Diagnostic Services, School of Veterinary Medicine, University of Glasgow. We also thank Nicola Munro, Craig Begley, Scott McCall and Catrina Boyd at the Veterinary Research Facility (University of Glasgow) for maintaining optimal husbandry conditions and comfort for the animals used in this study. We thank Julie Galbraith and Pawel Herzyk (Glasgow Polyomics, University of Glasgow) for their support with single-cell library preparation and sequencing. Finally, the authors would like to thank the Flow Cytometry Core Facility, University of Manchester, UK, for mass cytometry sample acquisition. This work was funded in part by a Wellcome Trust Institutional Strategic Support Fund award (316917-01 awarded to M.C.S.), a Society for Endocrinology Early Career Grant (316705/0 awarded to M.C.S.), and a Wellcome Centre for Integrative Parasitology FutureScope grant [174811-23] to M.C.S. This work was also funded in part by a Wellcome Trust Senior Research Fellowship (209511/Z/17/Z awarded to A.M.L.). J.F.Q. is funded by a Sir Henry Wellcome postdoctoral fellowship (221640/Z/20/Z awarded to J.F.Q.). P.C. is funded by a Wellcome Centre for Integrative Parasitology FutureScope grant to J.F.Q. (104111/Z/14/Z awarded to J.Q.). G.P.W. is funded by an MRC grant (MR/S009779/1). CB is funded by an MRC grant (MR/W018497/1). NAM is supported by the BBSRC Institute Strategic Programme (BBS/E/D/20002173 and BB/X010937/1). S.K. is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (DK97441, DK125281 and DK127575) and the Howard Hughes Medical Institute.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/11/3
Y1 - 2023/11/3
N2 - In the skin, Trypanosoma brucei colonises the subcutaneous white adipose tissue, and is proposed to be competent for forward transmission. The interaction between parasites, adipose tissue, and the local immune system is likely to drive the adipose tissue wasting and weight loss observed in cattle and humans infected with T. brucei. However, mechanistically, events leading to subcutaneous white adipose tissue wasting are not fully understood. Here, using several complementary approaches, including mass cytometry by time of flight, bulk and single cell transcriptomics, and in vivo genetic models, we show that T. brucei infection drives local expansion of several IL-17A-producing cells in the murine WAT, including T
H17 and Vγ6
+ cells. We also show that global IL-17 deficiency, or deletion of the adipocyte IL-17 receptor protect from infection-induced WAT wasting and weight loss. Unexpectedly, we find that abrogation of adipocyte IL-17 signalling results in a significant accumulation of Dpp4
+ Pi16
+ interstitial preadipocytes and increased extravascular parasites in the WAT, highlighting a critical role for IL-17 signalling in controlling preadipocyte fate, subcutaneous WAT dynamics, and local parasite burden. Taken together, our study highlights the central role of adipocyte IL-17 signalling in controlling WAT responses to infection, suggesting that adipocytes are critical coordinators of tissue dynamics and immune responses to T. brucei infection.
AB - In the skin, Trypanosoma brucei colonises the subcutaneous white adipose tissue, and is proposed to be competent for forward transmission. The interaction between parasites, adipose tissue, and the local immune system is likely to drive the adipose tissue wasting and weight loss observed in cattle and humans infected with T. brucei. However, mechanistically, events leading to subcutaneous white adipose tissue wasting are not fully understood. Here, using several complementary approaches, including mass cytometry by time of flight, bulk and single cell transcriptomics, and in vivo genetic models, we show that T. brucei infection drives local expansion of several IL-17A-producing cells in the murine WAT, including T
H17 and Vγ6
+ cells. We also show that global IL-17 deficiency, or deletion of the adipocyte IL-17 receptor protect from infection-induced WAT wasting and weight loss. Unexpectedly, we find that abrogation of adipocyte IL-17 signalling results in a significant accumulation of Dpp4
+ Pi16
+ interstitial preadipocytes and increased extravascular parasites in the WAT, highlighting a critical role for IL-17 signalling in controlling preadipocyte fate, subcutaneous WAT dynamics, and local parasite burden. Taken together, our study highlights the central role of adipocyte IL-17 signalling in controlling WAT responses to infection, suggesting that adipocytes are critical coordinators of tissue dynamics and immune responses to T. brucei infection.
KW - Adipose Tissue
KW - Adipose Tissue, White
KW - Animals
KW - Cachexia
KW - Cattle
KW - Humans
KW - Interleukin-17
KW - Mice
KW - Parasites
KW - Subcutaneous Fat
KW - Trypanosoma brucei brucei
U2 - 10.1038/s41467-023-42918-8
DO - 10.1038/s41467-023-42918-8
M3 - Article
C2 - 37923768
SN - 2041-1723
VL - 14
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 7070
ER -